TD Cowen Sticks to Its Buy Rating for Alnylam Pharma (ALNY)
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target of ...
TD Cowen downgrades Spero Therapeutics (SPRO) to a Hold
Spero Therapeutics (SPRO – Research Report) received a Hold rating and price target from TD Cowen analyst Ritu Baral yesterday. The ...